Paper Trader

Daily Portfolio Review Summary Market Conditions: VIX at 16.2 (calm, well below the 25 defensive threshold), S&P 500 down slightly (-0.29% today, -0.2% week), broad indices modestly weak but no signs of stress. Regime is normal — no need for defensive sizing. Portfolio Status: Equity $109,657 (up ~9.7% from the $100k base), drawdown from high-water mark is only 0.7% — well within mandate tolerance. Positions are diversified across tech, finance, and healthcare: | Position | Weight | P/L | |---|---|---| | META | 15.2% | +10.4% | | NVDA | 13.3% | +16.0% | | MSFT | 12.4% | +30.0% | | GOOGL | 11.5% | -3.3% | | AMZN | 9.8% | +7.3% | | JPM | 9.7% | +6.8% | | V | 7.9% | +8.3% | | JNJ | 4.8% | +5.5% | | AAPL | 3.0% | +7.3% | | UNH | 2.5% | -8.1% | | Cash | 9.91% | — | No position breaches the 20% single-name cap. All exposures are sized reasonably. Weak Positions Reviewed: - GOOGL (-3.3%): News flow highlights strong Google Cloud growth and a relatively cheap valuation vs. peers amid rate-fear-driven multiple compression across mega-cap tech. This looks like macro-driven volatility, not a fundamental deterioration — holding. - UNH (-8.1%): Coverage notes UnitedHealth's ongoing turnaround (stock +39% over 6 months from earlier lows), continued portfolio optimization (divesting Florida clinic stakes), and durable Medicare Advantage franchise despite plan-level noise. Position is small (2.5% of equity) — holding as a long-term healthcare anchor. Decision: No trades today. Rationale: Cash sits at 9.91% of equity, essentially at the mandate's 10% floor — there is no real room to add new buy exposure without breaching the cash buffer, and the daily buy budget (0/3 used) is better preserved for a genuine opportunity or a rebalancing need. Neither underperforming position shows a broken thesis; both are within normal volatility bands and their moves are explained by macro (rate fears hitting high-multiple tech) or transient headline noise (Medicare Advantage plan letters) rather than deteriorating fundamentals. Per the mandate, the boring choice — hold, stay diversified, protect the cash buffer — is the correct one today. Watching: - Treasury yield moves and their impact on mega-cap tech multiples (GOOGL, MSFT, META, NVDA collectively ~52% of the book) - UNH's Medicare Advantage plan disclosures due in October — could affect near-term sentiment - VIX trajectory — currently benign but up 13% week-over-week, worth monitoring for a shift toward the 25 defensive trigger - Cash buffer — will look to raise cash toward a more comfortable cushion above the 10% floor on any strength, rather than deploying further into an already-tight buy budget

Daily Portfolio Review — Summary Market Conditions: S&P 500 -0.4%, NASDAQ -0.46%, Dow -0.84% today (broader week trend still positive, +0.74%/+1.1%/+0.37%). VIX at 15.3 — well below the 25 defensive threshold, so no need for reduced sizing. Mild risk-off day, nothing alarming. Portfolio Status: Equity $109,945 (drawdown from HWM only 0.4%, per risk desk — healthy). All 10 positions are profitable or near-flat except UNH (-6.5%) and GOOGL (-1.6%), both minor. Position weights: | Position | Weight | P/L | |---|---|---| | META | 14.4% | +5.4% | | NVDA | 13.6% | +18.6% | | MSFT | 12.4% | +29.9% | | GOOGL | 11.6% | -1.6% | | AMZN | 9.9% | +9.3% | | JPM | 9.8% | +8.0% | | V | 8.0% | +9.5% | | JNJ | 4.8% | +5.9% | | AAPL | 3.0% | +7.8% | | UNH | 2.6% | -6.5% | No position exceeds the 20% cap (META highest at 14.4%), so no forced trims required. Cash Check: Cash is $10,866, or 9.88% of equity — already at/marginally below the 10% cash floor. This is the binding constraint today. Research on weak spots: - UNH (-6.5%): News flow is mixed-to-neutral — Medicare Advantage plan attrition and faster prior-authorization approvals are noted risks, but the stock is still up ~37-39% over 6 months and the turnaround narrative is intact. Small position (2.6%), not a fundamental red flag, no action needed. - GOOGL (-1.6%): Headlines are routine (earnings preview, Zacks estimates), no negative catalyst. Just short-term noise on an 11.6% core position. Decision: No trades today. Rationale: The mandate prioritizes capital preservation over chasing incremental rebalancing. Cash is already sitting essentially at the 10% floor, so any new buy would likely be rejected by the risk desk's cash-floor rule anyway. No position shows a fundamental deterioration severe enough to warrant trimming, and no position breaches the 20% concentration limit. With VIX low and drawdown minimal, the boring, mandate-aligned choice is to hold, let cash rebuild naturally, and avoid unforced action on a modestly red macro day. Watching: - Cash buffer — will look to add to underweight, high-quality names (AAPL, JNJ, UNH) once cash rebuilds above the 10% floor via dividends/trims. - UNH regulatory/reimbursement headlines for any escalation beyond routine noise. - MSFT/NVDA/META sizes — approaching the upper end of comfortable weight; will avoid adding further and consider trimming if any single name nears the 20% hard cap. - Broader market: today's -0.4-0.8% pullback with VIX still low looks like normal chop, not a regime shift — no defensive posture needed yet.

Daily Portfolio Review — Summary Portfolio status: Equity $108,918 (+8.9% since inception), cash $10,866 (9.97% of equity — sitting right at the 10% cash floor). Drawdown from HWM is only 1.4%, well inside the 10% circuit breaker. All 10 positions are diversified across tech, financials, healthcare, and consumer, with no single position above 14% of equity (well under the 20% cap). Market conditions: VIX 16.1 (down slightly today, still comfortably below the 25 defensive threshold and 35 freeze level). S&P 500 +0.17% today but -1.1% on the week; broad market is calm-to-slightly-soft, no volatility regime change. No basis for defensive de-risking. Position review: - Winners: MSFT (+31%), NVDA (+13.4%), JPM (+8.1%), V (+10.7%), JNJ (+10%), AMZN (+8%) — all intact, no thesis changes, letting them compound. - Laggards: UNH (-5.2%) and GOOGL (-1.7%) are the only positions in the red. News flow on UNH is actually constructive (prior-authorization rollback, stock rallying on the news, average analyst rating is Buy) — no reason to cut. GOOGL headlines showed no fundamental red flags, just a soft week consistent with the broader NASDAQ pullback (-1.65% weekly). - META essentially flat (+0.1%) — no action needed. Decision: No trades today. Rationale: (1) Cash is already at/below the 10% floor, so any new buy would either be rejected by the risk desk or push us in violation of mandate discipline — the mandate explicitly says treat the cash buffer as scarce and skip the trade when in doubt. (2) No position has a broken thesis or news catalyst warranting a sell — UNH's weakness looks like a buying opportunity, not a reason to exit, and GOOGL's dip is minor and macro-driven. (3) All risk metrics (drawdown, VIX, position sizing) are well within limits, so there's no defensive de-risking required either. Watching: - UNH for follow-through on the prior-auth policy change and whether analyst upgrades materialize — would consider adding if cash frees up. - GOOGL and broader NASDAQ softness (-1.65% weekly) for a bigger pullback that might present a better entry. - Cash buffer — will look for a trim candidate (likely the most extended winner, MSFT or NVDA) if a genuinely compelling new opportunity appears, rather than buying through the floor.

Daily Portfolio Review — Summary Portfolio Status: Equity $108,158.54 | Cash $10,865.83 (10.05% of equity) | Drawdown from HWM: 2.0% Market Conditions: - S&P 500 -0.66%, NASDAQ -1.24%, Dow -0.42% today — a modest broad pullback - VIX 15.91 (up 6.6% today) — still well within normal regime (defensive threshold is 25, freeze at 35) - No risk-desk restrictions triggered; circuit breaker armed but nowhere near the 10% threshold Position Review: | Position | Weight | Unrealized P/L | |---|---|---| | META | 13.4% | -3.6% | | NVDA | 12.9% | +11.3% | | MSFT | 12.9% | +32.8% | | GOOGL | 11.9% | -1.4% | | AMZN | 10.0% | +8.4% | | JPM | 10.0% | +8.3% | | V | 8.2% | +11.4% | | JNJ | 4.9% | +6.1% | | AAPL | 3.1% | +8.5% | | UNH | 2.6% | -5.8% | All positions are comfortably under the 20% concentration cap — no rebalancing forced by risk limits. Research on weak spots: - GOOGL (-1.4%): headlines cite a "brain drain" narrative, but also a large new Google-Fervo geothermal power deal for AI infrastructure — noise, not a fundamental red flag. Holding. - META (-3.6%): no negative company-specific news, just broader tech softness today. Holding. - UNH (-5.8%): Zacks and Trefis both frame UNH as reasonably/attractively valued relative to peers (CVS) even as margin recovery remains the swing factor. Modest position (2.6%), not adding risk by holding through the volatility. Trades Today: None Rationale for standing pat: 1. Cash is already sitting right at the 10% mandate floor ($10,865.83 / $108,158.54 = 10.05%). Any new buy would breach the cash buffer requirement before even hitting the risk desk's floor check. 2. No position is showing a fundamental breakdown — today's softness (GOOGL, META, UNH) looks like normal noise/rotation, not a thesis-breaking event. 3. Drawdown is a benign 2% from highs, VIX is calm, and nothing in the news flow justifies trimming winners (MSFT, NVDA, JPM, V) or panic-selling laggards. 4. Per mandate: "when in doubt, the boring choice is the mandate-aligned choice" — today is a hold day, preserving the cash buffer and letting the diversified book ride through a routine down day. Watching: - VIX trend — a move toward 25 would trigger defensive sizing; will reassess buy sizing then - GOOGL "brain drain" narrative for any concrete signs of talent/product execution risk - UNH margin trajectory into next earnings — valuation looks fair but execution is the swing factor - Cash buffer — will look for a trim/rotation opportunity to free capital for the next high-conviction add rather than force a buy against the floor

Daily Portfolio Review — Summary Market conditions: S&P 500 -0.45%, Nasdaq -0.45%, Dow -0.61% on the day; VIX ticked up 5.9% to 15.3 but remains well below the defensive (25) and freeze (35) thresholds. Broader tape softness tied to Fed rate-hike expectations and Iran/oil headline risk — not a regime-changing event. Portfolio status: Equity $108,946 (+8.9% since inception), drawdown from HWM only 1.3%, well inside the 10% breaker. Cash sits at $10,866 = 9.97% of equity — essentially at the 10% cash floor. Position sizing is healthy and diversified, with nothing near the 20% single-name cap: | Position | % of Equity | P&L | |---|---|---| | META | 13.5% | -2.6% | | NVDA | 13.0% | +12.5% | | MSFT | 12.9% | +34.2% | | GOOGL | 11.9% | ~flat | | AMZN | 10.2% | +11.2% | | JPM | 9.9% | +7.9% | | V | 8.2% | +11.8% | | JNJ | 4.8% | +4.6% | | AAPL | 3.0% | +7.8% | | UNH | 2.6% | -6.9% | Research on laggards: - UNH (-6.9%): News flow is actually constructive — analysts see it as undervalued vs. peers, Optum/UnitedHealthcare results improving. Tepper's exit is a sentiment overhang, not a fundamental red flag. No thesis break; small position size already limits risk. - META (-2.6%): Bernstein flagged Meta potentially overtaking Google in search-ad revenue via AI targeting — a bullish structural signal, not bearish. Minor pullback looks like normal noise, not a reason to trim a name with improving competitive position. - GOOGL (flat): No adverse news; AI/cloud capex debate ongoing but no red flags specific to Alphabet. Decision: No trades today. Rationale: 1. Cash is already at the 10% floor — deploying more capital would breach the risk desk's hard limit, and the mandate explicitly says to treat the buy budget as scarce. 2. No position breaches concentration limits or shows thesis-breaking fundamentals; today's weakness in UNH/META is sentiment/macro-driven, not company-specific deterioration. 3. VIX and drawdown are both comfortably within normal-regime bounds — no defensive de-risking is warranted, and no case for adding risk either given the cash constraint. 4. Staying put preserves the current healthy diversification and keeps the "boring choice" bias the mandate calls for. Watching: - Fed rate decision (Sept 16) and oil/geopolitical headlines — main sources of near-term volatility. - UNH for any further deterioration beyond sentiment (would revisit if Optum/UNH fundamentals actually crack). - Cash buffer — will look to trim if any position drifts toward the 20% cap (META/NVDA/MSFT are the ones to watch) to free up flexibility for future opportunities.

Daily Portfolio Review — Summary Market conditions: Calm and constructive — S&P 500 +0.04% today, VIX at 15.6 (well below the 25 defensive threshold), broad indices flat-to-up on the week. No macro reason for defensiveness. Portfolio status: Equity $108,321 (+8.3% since inception), drawdown from high-water mark only 1.9% (breaker at 10%) — well within limits. Cash is $10,866, or 10.03% of equity — essentially sitting right on the 10% cash floor. All 10 positions are within the 20% single-position cap (largest is META at 13.4%, NVDA/MSFT/GOOGL all ~12-13%). Positions reviewed for weakness: - META (-3.5% unrealized, -7.4% over 1mo): The pullback looks sentiment-driven, not fundamental — revenue growth is a strong 28%, margins ~30%, and forward P/E has compressed to 16.3x, cheap for the growth profile. News flow is actually a net positive: Meta just resolved a major legal overhang (the $18B child-safety settlement), removing uncertainty, and the stock rallied on the news. No action — thesis intact, position not oversized. - UNH (-4.2% unrealized): Fundamentals are genuinely soft (revenue growth ~0.4%, thin 3.1% margins, commercial-book cost pressure flagged by analysts), but the stock has bounced hard (+7.5% in a month, +18% off recent lows) as Medicare margins improve. Position is small at just 2.65% of equity, so risk exposure is limited. No action — too small to matter, trend improving, will monitor commercial-cost commentary. Trading decision: No trades today. Rationale: Cash is only $33 above the mandated 10% floor, leaving essentially zero room to add to any position without breaching a hard risk limit — and per mandate, "when in doubt, the boring choice is mandate-aligned: skip the trade, keep the cash buffer." Neither weak position (META, UNH) shows a deteriorating thesis severe enough to justify trimming into strength-adjacent conditions (low VIX, low drawdown). Forcing a buy today would mean either breaching the cash floor or trimming a healthy winner just to fund it — neither is warranted. Watching: - META: legal overhang cleared, watch for stabilization/reversal in the multiple compression; would consider adding on further weakness *if* cash allows. - UNH: commercial segment cost trend in next earnings — this determines whether the bounce is durable or a dead-cat recovery. - NVDA: earnings upcoming per news flow — position is 12.75% of equity, sized appropriately, no action needed pre-print. - Cash buffer: at the floor — any new opportunity will require either a trim elsewhere or organic cash build from dividends/trimming winners.

Daily Portfolio Review — Summary Market Conditions: S&P 500 +0.39% today, NASDAQ +0.82%, VIX at 15.8 (well below the 25 defensive threshold). Calm, orderly market — no regime adjustment needed. Portfolio Health: - Equity: $108,363 | Cash: $10,866 (10.03% of equity) - Drawdown from HWM: 1.9% (breaker at 10%) — healthy - All 10 positions within the 20% single-position cap (largest is META at 13.4%) - Broad-based gains: MSFT +29%, AMZN +11.6%, NVDA +9.9%, V +12.4%, JPM +7.4% all comfortably green Positions Reviewed for Weakness: 1. META (-3.3% unrealized, -7.2% over 1mo): Pulled back on data-center capex jitters, but fundamentals remain excellent — 28% revenue growth, ~30% margins, forward P/E of just 16.4x. This looks like a valuation-driven dip in a high-quality compounder, not a deterioration in the business. No action — holding. 2. UNH (-5.7% unrealized): Facing headline risk (IRS transfer-pricing scrutiny, commercial-book cost pressure), but the stock is actually up 5.9% over the past month and trades at a cheap 17.7x forward P/E. Small position (2.6% of book). No action — holding through the recovery. Trading Decision: No trades today. Rationale: - Cash sits right at the 10% floor ($10,866 vs ~$10,836 minimum) — there is essentially no room to deploy capital today without breaching the risk desk's cash buffer, and manufacturing room by trimming quality names just to chase a marginal buy isn't mandate-aligned. - Neither weak position (META, UNH) shows a fundamental thesis break — both are cheap on forward earnings and either recovering (UNH) or dipping on sentiment rather than fundamentals (META). Selling into weakness here would work against the "steady compounding" mandate. - No position breaches concentration limits, VIX is calm, and drawdown is minimal — the boring choice (hold) is correct. What I'm watching: - META's data-center capex narrative and Q3 print — would reassess if margins/growth actually deteriorate, not just on price action. - UNH's IRS scrutiny outcome and commercial cost trends — a re-rating catalyst either way. - Cash buffer sitting right at the floor — will monitor for any inflows/appreciation that create real room to add, rather than forcing a trade.

Daily Portfolio Review — Summary Portfolio status: Equity $107,330.31 (+7.3% since inception), cash $10,865.83 (10.12% of equity). All 9 positions are within the 20% single-position cap (largest is META at 13.1%, then NVDA 12.7%, MSFT 12.5%, GOOGL 12.3%). Portfolio is well diversified across tech, finance, healthcare, and consumer. Market conditions: VIX 15.84 (up slightly today but well below the 25 defensive / 35 freeze thresholds). S&P 500 -0.41%, NASDAQ -1.01% today — a mild risk-off day, likely tech-led ahead of NVDA earnings. Drawdown from HWM is only 2.8%, well inside the 10% breaker. No regime restrictions in effect. Position review: - META (-6.7% unrolled, -10.5% over 1mo): Weakness looks sentiment/legal-news driven (antitrust trial headlines), not fundamental — forward P/E 15.8, revenue growth 28%, margins ~30%. Quality name on a pullback. Hold, no reason to sell a temporary dip on strong fundamentals. - UNH (-5.5% unrealized, but +6.1% over the past month): Facing IRS transfer-pricing scrutiny (headline risk), but stock is already recovering and forward P/E of 17.7 is reasonable for the sector. Small position (2.6% of equity). Hold — watching the IRS story for developments. - All other positions (AAPL, AMZN, GOOGL, JPM, JNJ, MSFT, NVDA, V) show solid unrealized gains and no fundamental red flags. Trades executed: None. Rationale for no action today: Cash is sitting at $10,865.83 against a hard floor of $10,733 (10% of equity) — leaving only ~$130 of buyable room, effectively zero. Per mandate, I'm treating the cash buffer as scarce and not forcing a trade just to deploy capital. Nothing in the portfolio shows a fundamental deterioration that would justify selling into weakness (META and UNH both look like temporary pullbacks with intact earnings power, not broken theses). The boring choice — hold, stay diversified, preserve the cash buffer — is the mandate-aligned choice given today's market backdrop (VIX calm, but tech under modest pressure into NVDA earnings). Watching: - NVDA Q2 earnings (Aug 26) — key catalyst for AI-trade sentiment, could swing NVDA/META/MSFT/GOOGL together. - META antitrust trial resumption — headline risk, but no fundamental impact yet. - UNH IRS transfer-pricing scrutiny — monitoring for escalation vs. resolution. - Cash buffer — will look to trim or rebalance a stretched winner (e.g., MSFT +27.8%) if a compelling opportunity arises and more buy capacity is needed, rather than breach the cash floor.